Mr Mason Freeman

KANDO id: 41423

Bio

Mason Freeman, M.D. joined 5AM Ventures as a Science Advisor in 2007 and became a Venture Partner in 2008. He currently serves as Chief of the Lipid Metabolism Unit and Director of Translational Medicine at Massachusetts General Hospital, Harvard Medical School. Trained in internal medicine and endocrinology, Dr. Freeman has spent the past twenty years studying the trafficking of cholesterol into and out of macrophages. Dr. Freeman founded and still directs the Lipid Clinic at MGH and is an internationally recognized expert in the treatment of lipid disorders. From 2005 - 2007, Dr. Freeman was Vice President and Global Head of Translational Medicine for Cardiovascular, Diabetes, and Metabolic Diseases at the Novartis Institutes of Biomedical Research in Cambridge, MA. He is chair of the scientific advisory board for translational medicine at Novartis and a member of the scientific program committee for the American Heart Association. Dr. Freeman received his A.B. from Harvard College and his M.D. from the University of California, San Francisco.

Education